Published on
Jan 21, 2026
Biosimilar Competition Linked to Lower Out-of-Pocket Costs for Medicare Patients
Biosimilar competition was associated with meaningful reductions in out-of-pocket spending for patients with Medicare coverage receiving clinician-administered biologics, according to a new analysis of national claims data.1 The findings suggested that, …
Source:
The Center for Biosimilars
-
Pending
